Evidence map›Paper›PMID 39327922›Full record

ArticlePsychological medicine2024

Validation of the imperial psychedelic predictor scale.

Michael Angyus, Sarah Osborn, Eline Haijen, David Erritzoe, Joseph Peill, Taylor Lyons, Hannes Kettner, Robin Carhart-Harris

Erratum issuedAbstract read
In one paragraph

Article in Psychological medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. On Minimizing Risk and Harm in the Use of Psychedelics.Psychiatric research and clinical practice · 2025
    Article
  7. Psychological effects of psychedelics in adolescents.Frontiers in child and adolescent psychiatry · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Michael AngyusDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-9216-5029
Sarah OsbornDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.
Eline HaijenDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.
David ErritzoeDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.
Joseph PeillDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.
Taylor LyonsDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.
Hannes KettnerDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.
Robin Carhart-HarrisDepartment of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccess to psychedelic drugs is liberalizing, yet responses are highly unpredictable. It is therefore imperative that we improve our ability to predict the nature of the acute psychedelic experience to improve safety and optimize potential therapeutic outcomes. This study sought to validate the 'Imperial Psychedelic Predictor Scale' (IPPS), a short, widely applicable, prospective measure intended to be predictive of salient dimensions of the psychedelic experience.

methodsUsing four independent datasets in which the IPPS was completed prospectively - two online surveys of 'naturalistic' use (

resultsOur approach produced a 9-item scale with good internal consistency (Cronbach's

conclusionsTogether, these data suggest that the IPPS is predictive of relevant acute features of the psychedelic experience in a broad range of contexts. We hope that this brief 9-item scale will be widely adopted for improved knowledge of psychedelic preparedness in controlled settings and beyond.

Indexed as

pharmaceuticalspredicting psychedelic responsepsychedelic preparationpsychedelicspsychometricssafetyset and setting

Identifiers

PMID39327922
PMCPMC11496213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.